Welcome: Guest | Site Use Options | Register | Login |

Unigene Laboratories Inc

Profile last edited on: 5/16/19
81 Fulton Street
Boonton, NJ 07005
  (973) 265-1100
Business Identifier: Oral peptide therapeutics
Public Profile:
Unigene Laboratories Inc had built a robust portfolio of proprietary partnerships in the drug class based on the Companys Peptelligence platform, until it went out of business in 2013 following bankrupcy proceedings. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies. The Companys first product to market, Fortical, a nasal calcitonin product, received FDA approval in 2005 and was marketed by Upsher-Smith for the treatment of postmenopausal osteoporosis. Pivotal clinical programs included an oral calcitonin licensed to Tarsa Therapeutics, now in Phase 3 testing for the treatment of osteoporosis. Other validating relationships included an oral parathyroid hormone entering Phase 2 in the first quarter of 2011 and licensed to GlaxoSmithKline. In addition, Unigene had a manufacturing license agreement with Novartis, which is completing 3 Phase III studies of oral calcitonin for the treatment of osteoporosis and osteoarthritis. Unigenes technologies have extensive clinical and partner

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Identification of Novel Alpha Amidated Peptide Hormones
Oral Recombinant PTH(1-31)NH2 for Osteoporosis

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920